Photo taken rom Erman Akkus/X
Feb 10, 2024, 15:18
Erman Akkus: Localized pancreatic adenocancer treated with initial neoadjuvant FOLFIRINOX
Erman Akkus, Medical Oncology Fellow at Ankara University, shared on X/Twitter:
“Localized pancreatic adenocancer treated with initial neoadjuvant FOLFIRINOX.
– ABC scoring.
– Anatomy (resectable, borderline resectable, or locally advanced), biology (baseline Ca19-9 >500), and condition (WHO performance status ≥1) were independent poor prognostic factors.
– Locally advanced=2 points, each of others=1 point,
– Survival graphic:
– A simple and practical way to gauge the prognosis of patients with localized pancreatic cancer in whom neoadjuvant FOLFIRINOX is planned.”
Source: Erman Akkus/X
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Jan 17, 2025, 18:14
Jan 17, 2025, 18:02
Jan 17, 2025, 17:53
Jan 17, 2025, 17:45
Jan 17, 2025, 17:28
Jan 17, 2025, 17:20
Jan 17, 2025, 17:15
Jan 17, 2025, 17:11
Jan 17, 2025, 17:03